Go Pro

Greenlane (GNLN) Competitors

Greenlane logo
$2.94 +0.17 (+5.96%)
As of 02:37 PM Eastern
This is a fair market value price provided by Massive. Learn more.

GNLN vs. AMST, DTSS, IPST, AUUD, and ENTO

Should you buy Greenlane stock or one of its competitors? Greenlane's main competitors and comparable companies include Amesite (AMST), Datasea (DTSS), Heritage Distilling (IPST), Auddia (AUUD), and Entero Therapeutics (ENTO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "application software" industry.

How does Greenlane compare to Amesite?

Greenlane (NASDAQ:GNLN) and Amesite (NASDAQ:AMST) are both small-cap technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability.

Amesite has a net margin of -873.02% compared to Greenlane's net margin of -4,630.56%. Amesite's return on equity of -154.31% beat Greenlane's return on equity.

Company Net Margins Return on Equity Return on Assets
Greenlane-4,630.56% -282.11% -240.74%
Amesite -873.02%-154.31%-129.67%

In the previous week, Amesite's average media sentiment score of 0.49 beat Greenlane's score of 0.00 indicating that Amesite is being referred to more favorably in the news media.

Company Overall Sentiment
Greenlane Neutral
Amesite Neutral

Greenlane has a beta of 1.88, indicating that its stock price is 88% more volatile than the broader market. Comparatively, Amesite has a beta of 1, indicating that its stock price has a similar volatility profile to the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Greenlane
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Amesite
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

14.0% of Greenlane shares are owned by institutional investors. Comparatively, 3.6% of Amesite shares are owned by institutional investors. 13.0% of Greenlane shares are owned by company insiders. Comparatively, 36.5% of Amesite shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Amesite has lower revenue, but higher earnings than Greenlane. Amesite is trading at a lower price-to-earnings ratio than Greenlane, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Greenlane$2.21M0.92-$85.58M-$58.92N/A
Amesite$341.44K19.57-$3.62M-$0.63N/A

Summary

Amesite beats Greenlane on 8 of the 12 factors compared between the two stocks.

How does Greenlane compare to Datasea?

Greenlane (NASDAQ:GNLN) and Datasea (NASDAQ:DTSS) are both small-cap technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership.

14.0% of Greenlane shares are owned by institutional investors. Comparatively, 82.1% of Datasea shares are owned by institutional investors. 13.0% of Greenlane shares are owned by company insiders. Comparatively, 50.7% of Datasea shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Datasea had 1 more articles in the media than Greenlane. MarketBeat recorded 1 mentions for Datasea and 0 mentions for Greenlane. Datasea's average media sentiment score of 0.98 beat Greenlane's score of 0.00 indicating that Datasea is being referred to more favorably in the news media.

Company Overall Sentiment
Greenlane Neutral
Datasea Positive

Datasea has a net margin of -4.80% compared to Greenlane's net margin of -4,630.56%. Datasea's return on equity of -88.98% beat Greenlane's return on equity.

Company Net Margins Return on Equity Return on Assets
Greenlane-4,630.56% -282.11% -240.74%
Datasea -4.80%-88.98%-37.33%

Datasea has higher revenue and earnings than Greenlane. Datasea is trading at a lower price-to-earnings ratio than Greenlane, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Greenlane$2.21M0.92-$85.58M-$58.92N/A
Datasea$56.89M0.12-$5.09M-$0.32N/A

Greenlane has a beta of 1.88, indicating that its stock price is 88% more volatile than the broader market. Comparatively, Datasea has a beta of 0.79, indicating that its stock price is 21% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Greenlane
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Datasea
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Datasea beats Greenlane on 10 of the 13 factors compared between the two stocks.

How does Greenlane compare to Heritage Distilling?

Heritage Distilling (NASDAQ:IPST) and Greenlane (NASDAQ:GNLN) are both small-cap technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership and dividends.

14.0% of Greenlane shares are held by institutional investors. 3.7% of Heritage Distilling shares are held by insiders. Comparatively, 13.0% of Greenlane shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Heritage Distilling has a beta of 5.38, suggesting that its stock price is 438% more volatile than the broader market. Comparatively, Greenlane has a beta of 1.88, suggesting that its stock price is 88% more volatile than the broader market.

In the previous week, Heritage Distilling's average media sentiment score of 1.89 beat Greenlane's score of 0.00 indicating that Heritage Distilling is being referred to more favorably in the media.

Company Overall Sentiment
Heritage Distilling Very Positive
Greenlane Neutral

Heritage Distilling has a net margin of -1,875.66% compared to Greenlane's net margin of -4,630.56%. Heritage Distilling's return on equity of -242.58% beat Greenlane's return on equity.

Company Net Margins Return on Equity Return on Assets
Heritage Distilling-1,875.66% -242.58% -201.22%
Greenlane -4,630.56%-282.11%-240.74%

Heritage Distilling currently has a consensus price target of $164.00, indicating a potential upside of 3,827.20%. Given Heritage Distilling's stronger consensus rating and higher possible upside, equities analysts plainly believe Heritage Distilling is more favorable than Greenlane.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Heritage Distilling
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Greenlane
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Greenlane has lower revenue, but higher earnings than Heritage Distilling. Greenlane is trading at a lower price-to-earnings ratio than Heritage Distilling, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heritage Distilling$10.12M0.30-$137.71M-$311.78N/A
Greenlane$2.21M0.92-$85.58M-$58.92N/A

Summary

Heritage Distilling beats Greenlane on 10 of the 15 factors compared between the two stocks.

How does Greenlane compare to Auddia?

Greenlane (NASDAQ:GNLN) and Auddia (NASDAQ:AUUD) are both small-cap technology companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, media sentiment, analyst recommendations, dividends, earnings and institutional ownership.

Greenlane has a beta of 1.88, suggesting that its stock price is 88% more volatile than the broader market. Comparatively, Auddia has a beta of 0.5, suggesting that its stock price is 50% less volatile than the broader market.

Auddia has a net margin of 0.00% compared to Greenlane's net margin of -4,630.56%. Auddia's return on equity of -175.41% beat Greenlane's return on equity.

Company Net Margins Return on Equity Return on Assets
Greenlane-4,630.56% -282.11% -240.74%
Auddia N/A -175.41%-153.38%

14.0% of Greenlane shares are held by institutional investors. 13.0% of Greenlane shares are held by insiders. Comparatively, 1.6% of Auddia shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Auddia has lower revenue, but higher earnings than Greenlane. Auddia is trading at a lower price-to-earnings ratio than Greenlane, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Greenlane$2.21M0.92-$85.58M-$58.92N/A
Auddia$7.58K800.36-$7.69M-$18.04N/A

In the previous week, Auddia had 3 more articles in the media than Greenlane. MarketBeat recorded 3 mentions for Auddia and 0 mentions for Greenlane. Greenlane's average media sentiment score of 0.00 equaled Auddia'saverage media sentiment score.

Company Overall Sentiment
Greenlane Neutral
Auddia Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Greenlane
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Auddia
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Auddia beats Greenlane on 7 of the 12 factors compared between the two stocks.

How does Greenlane compare to Entero Therapeutics?

Entero Therapeutics (NASDAQ:ENTO) and Greenlane (NASDAQ:GNLN) are both small-cap technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, risk, profitability, valuation and earnings.

In the previous week, Entero Therapeutics' average media sentiment score of 0.00 equaled Greenlane'saverage media sentiment score.

Company Overall Sentiment
Entero Therapeutics Neutral
Greenlane Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Entero Therapeutics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Greenlane
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Entero Therapeutics has a net margin of 0.00% compared to Greenlane's net margin of -4,630.56%. Greenlane's return on equity of -282.11% beat Entero Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Entero TherapeuticsN/A -461.02% -14.72%
Greenlane -4,630.56%-282.11%-240.74%

Entero Therapeutics has a beta of 1.19, meaning that its stock price is 19% more volatile than the broader market. Comparatively, Greenlane has a beta of 1.88, meaning that its stock price is 88% more volatile than the broader market.

Entero Therapeutics has higher earnings, but lower revenue than Greenlane. Entero Therapeutics is trading at a lower price-to-earnings ratio than Greenlane, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Entero TherapeuticsN/AN/A-$18.06M-$1.69N/A
Greenlane$2.21M0.92-$85.58M-$58.92N/A

12.3% of Entero Therapeutics shares are owned by institutional investors. Comparatively, 14.0% of Greenlane shares are owned by institutional investors. 0.8% of Entero Therapeutics shares are owned by company insiders. Comparatively, 13.0% of Greenlane shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Greenlane beats Entero Therapeutics on 6 of the 10 factors compared between the two stocks.

Get Greenlane News Delivered to You Automatically

Sign up to receive the latest news and ratings for GNLN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GNLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GNLN vs. The Competition

MetricGreenlaneSoftware IndustryTechnology SectorNASDAQ Exchange
Market Cap$2.04M$15.70B$29.28B$12.70B
Dividend YieldN/A3.39%2.73%11.69%
P/E Ratio-0.05137.1574.7325.00
Price / Sales0.921,295.25586.7977.76
Price / CashN/A49.6349.5252.85
Price / Book0.087.329.156.08
Net Income-$85.58M$437.25M$678.51M$348.75M
7 Day Performance-2.17%-1.25%-2.11%-1.72%
1 Month Performance52.07%3.51%1.68%3.51%
1 Year Performance-88.71%3.42%183.98%14.72%

Greenlane Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GNLN
Greenlane
0.9353 of 5 stars
$2.94
+6.0%
N/A-89.8%$2.04M$2.21MN/A260
AMST
Amesite
0.7965 of 5 stars
$1.12
-3.4%
N/A-62.0%$7.60M$110KN/A20
DTSS
Datasea
0.6176 of 5 stars
$0.72
-0.5%
N/A-69.1%$7.50M$71.62MN/A120
IPST
Heritage Distilling
2.5803 of 5 stars
$7.78
-9.3%
$164.00
+2,008.0%
-97.5%$6.19M$10.12MN/AN/A
AUUD
Auddia
0.3732 of 5 stars
$0.97
-4.0%
N/A-94.2%$5.86MN/AN/A20

Related Companies and Tools


This page (NASDAQ:GNLN) was last updated on 9/2/2026 by MarketBeat.com Staff.
From Our Partners